Allena Pharmaceuticals Receives $15,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3613c363-bf7a-4dac-9cca-d6e1829f7a4e&Preview=1
Date
11/17/2011
Company Name
Allena Pharmaceuticals
Mailing Address
One Newton Executive Park Newton, MA 02462
Company Description
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
Website
http://www.allenapharma.com
Transaction Type
Venture Equity
Transaction Amount
$15,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds from the financing will be used to accelerate the development of Allena’s non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
M&A Terms
Venture Investor
Bessemer Venture Partners
Venture Investor
Frazier Healthcare Ventures
Venture Investor
Third Rock Ventures
Venture Investor
Undisclosed